JAN 04, 2017 6:30 PM PST

Scientists Unveil Unique Factors Contributing to Autoimmune Disease

WRITTEN BY: Kara Marker

Many autoimmune diseases come in waves, where symptoms temporarily get worse followed by a time of little to no signs of disease. There are a lot of factors that govern why and how an autoimmune disorder occurs, but a recent study was focused specifically on the quality of autoimmunity that causes flare-ups of disease. The same study ultimately resulted in the revealing of two key factors involved in this process, providing doctors and patients new hope for an autoimmune treatment.

Source: OnlineHealth.wiki

From the Schepens Eye Research Institute of Massachusetts Eye and Ear Infirmary, researchers focused on a mouse model of dry eye disease, an autoimmune disease that shares molecular similarities with multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, and another chronic inflammatory eye disorder called uveitis. The common denominator is Th17 cells, which can continue living in the circulation for a relatively long time as memory cells.

They quickly identified interleukins (IL) 7 and 15, immune cytokines secreted by other immune cells that act as cell-signaling proteins. IL-7 and IL-15 play the role of memory regulation for Th17 cells, the researchers discovered. This enlightenment meant two new targets for treatments.

"By selectively targeting the production and expression of IL-7 and IL-15, we may be able to prevent the development of chronic autoimmune disorders,” explained senior author Reza Dana, MD, Msc, MPH. Dana’s study is the first to uncover how Th17 cells maintain memory.

During the study, when scientists neutralized IL-7 and IL-15, the result was a significant decrease in the number of memory Th17 cells, further highlighting the potential for the two interleukins as targets for a new autoimmune disease treatment.

"In the case of dry eye disease, many of the treatments are showing limited efficacy in patients that do not have a highly inflamed eye," Dana said. "Targeting the chronic, immune nature of autoimmune diseases may be a better strategy for controlling these conditions."

Dana’s study was recently published in the Journal of Autoimmunity.

Source: Massachusetts Eye and Ear Infirmary

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 09, 2020
Immunology
MAR 09, 2020
Mobilizing the brain's immune cells boosts memory
A study by researchers at Australia’s RMIT University has uncovered a surprising connection between immune cells i ...
APR 23, 2020
Immunology
APR 23, 2020
COVID "Immunity Passports" Are a No-Go
  Authorities are caught between dealing with the competing urgencies of abating the COVID-19 health crisis and the ...
APR 10, 2020
Drug Discovery & Development
APR 10, 2020
Cancer Therapy Drug Reverses Kidney Damage
According to a study published in the journal Science Translational Medicine, a therapeutic previously used for cancer t ...
APR 29, 2020
Immunology
APR 29, 2020
New Immune Cell Discovered in Mammary Ducts
Dubbed “ductal macrophages,” newly discovered immune cells found in breast tissue offer fresh promise for fu ...
MAY 15, 2020
Immunology
MAY 15, 2020
Support the Microbiome So the Immune System Can Do Its Job
Research has long connected the human microbiome and immune system function, and now a recent study pinpoints a key poin ...
MAY 21, 2020
Drug Discovery & Development
MAY 21, 2020
Molecular 'Switch' Makes Autoimmune Drugs Fight Cancer
Researchers from the Antibody and Vaccine Group at the University of Southampton, England, have identified a way to repu ...
Loading Comments...